2026

Pea, A. et al. (2026) Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreas. Nature Communications, (doi: 10.1038/s41467-026-69762-w) (PMID:41775703) (Early Online Publication)

2024

Pea, A. et al. (2024) Clonal evolutionary analysis reveals patterns of malignant transformation in pancreatic cancer from Intraductal Papillary Mucinous IPMN Neoplasms (IPMN). bioRxiv, August 6. (doi: 10.1101/2024.08.02.606217)

O’Rourke, C. J. et al. (2024) Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy. Gut, 73(3), pp. 496-508. (doi: 10.1136/gutjnl-2023-330748) (PMID:37758326) (PMCID:PMC10894814)

2023

Dreyer, S. B. et al. (2023) The impact of molecular subtyping on pathological staging of pancreatic cancer. Annals of Surgery, 277(2), e396-e405. (doi: 10.1097/SLA.0000000000005050) (PMID:36745763) (PMCID:PMC9831035)

2021

Casolino, R. et al. (2021) Homologous recombination deficiency in pancreatic cancer: a systematic review and prevalence meta-analysis. Journal of Clinical Oncology, 39(23), pp. 2617-2631. (doi: 10.1200/JCO.20.03238) (PMID:34197182) (PMCID:PMC8331063)

Froeling, Fieke E.M. ORCID: https://orcid.org/0000-0002-8653-8164, Casolino, Raffaella, Pea, Antonio, Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 and Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078 (2021) Molecular subtyping and precision medicine for pancreatic cancer. Journal of Clinical Medicine, 10(1), 149. (doi: 10.3390/jcm10010149) (PMID:33406790) (PMCID:PMC7794969)

Pea, Antonio, Jamieson, Nigel B. ORCID: https://orcid.org/0000-0002-9552-4725 and Braconi, Chiara ORCID: https://orcid.org/0000-0003-4835-1259 (2021) Biology and clinical application of regulatory RNAs in hepatocellular carcinoma. Hepatology, 73(S1), pp. 38-48. (doi: 10.1002/hep.31225) (PMID:32160335)

Articles

Pea, A. et al. (2026) Clonal evolutionary analysis reveals patterns of malignant transformation of Intraductal Papillary Mucinous Neoplasms of the pancreas. Nature Communications, (doi: 10.1038/s41467-026-69762-w) (PMID:41775703) (Early Online Publication)

Pea, A. et al. (2024) Clonal evolutionary analysis reveals patterns of malignant transformation in pancreatic cancer from Intraductal Papillary Mucinous IPMN Neoplasms (IPMN). bioRxiv, August 6. (doi: 10.1101/2024.08.02.606217)

O’Rourke, C. J. et al. (2024) Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy. Gut, 73(3), pp. 496-508. (doi: 10.1136/gutjnl-2023-330748) (PMID:37758326) (PMCID:PMC10894814)

Dreyer, S. B. et al. (2023) The impact of molecular subtyping on pathological staging of pancreatic cancer. Annals of Surgery, 277(2), e396-e405. (doi: 10.1097/SLA.0000000000005050) (PMID:36745763) (PMCID:PMC9831035)

Casolino, R. et al. (2021) Homologous recombination deficiency in pancreatic cancer: a systematic review and prevalence meta-analysis. Journal of Clinical Oncology, 39(23), pp. 2617-2631. (doi: 10.1200/JCO.20.03238) (PMID:34197182) (PMCID:PMC8331063)

Froeling, Fieke E.M. ORCID: https://orcid.org/0000-0002-8653-8164, Casolino, Raffaella, Pea, Antonio, Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 and Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078 (2021) Molecular subtyping and precision medicine for pancreatic cancer. Journal of Clinical Medicine, 10(1), 149. (doi: 10.3390/jcm10010149) (PMID:33406790) (PMCID:PMC7794969)

Pea, Antonio, Jamieson, Nigel B. ORCID: https://orcid.org/0000-0002-9552-4725 and Braconi, Chiara ORCID: https://orcid.org/0000-0003-4835-1259 (2021) Biology and clinical application of regulatory RNAs in hepatocellular carcinoma. Hepatology, 73(S1), pp. 38-48. (doi: 10.1002/hep.31225) (PMID:32160335)